Earache: Clinical Trials

11 trials for Earache, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 3 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 33Completed 2, Terminated 1
Not applicable1Recruiting 1
Phase 11Completed 1
Phase 41Withdrawn 1

Follow Earache: new trials by email Literature Review of Earache trials Research Report on Earache

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Peloid Therapy in Temporomandibular Joint Dysfunction
Local Peloid Therapy - Temporomandibular Disorders (TMDs), Pain
Not applicableRecruitingUşak University402026-04-012026-07-02
Validating and AI Software for Assessment of Children With Ear Concerns
Otalgia, Otitis Media
Not yet recruitingGlimpse Diagnostics, Inc.6582026-01-012025-11-21
The Effect of Postoperative Eustachian Milking Maneuver on Eustachian Tube Dysfunction
Eustachian milking maneuver with routine postoperative treatment protocol, Routine postoperative treatment protocol - Postoperative Middle Ear Pressure, Otalgia
CompletedKaraman Training and Research Hospital802024-10-222025-04-17
Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.
Pregabalin, Placebo - Earache
Phase 2TerminatedUniversity Hospital, Lille422015-06-052019-10-14
Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media
AR01, Glycerin ear drops - Acute Otitis Media
Phase 3CompletedArbor Pharmaceuticals, Inc.3042013-12-012015-04-08
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
AR01, Placebo Comparator - Acute Otitis Media
Phase 3TerminatedArbor Pharmaceuticals, Inc.1782013-12-012017-01-24
Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
Ciprodex Otic Suspension, Ciprodexa Otic Foam - Otitis Externa, Otorhinolaryngologic Diseases
Phase 2CompletedOtic Pharma1002011-07-012011-11-02
Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
0.3% Ciprofloxacin Ear Drops, FoamOtic Cipro - Otitis Externa, Otorhinolaryngologic Diseases
Phase 2CompletedOtic Pharma702010-07-012011-03-15
Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
0.3% Ciprofloxacin Ear Drops, 0.3% Ciprofloxacin Foam Otic Cipro - Otitis Externa, Otorhinolaryngologic Diseases
Phase 1 / Phase 2CompletedOtic Pharma1002009-05-012009-12-24
A Phase III Study of an Otic Formulation in Acute Otitis Externa
Moxidex otic solution, Moxifloxacin otic solution, Dexamethasone phosphate otic solution - Acute Otitis Externa
Phase 3CompletedAlcon Research9902008-06-012012-12-03
The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux
Omeprazole, Ranitidine, Pantoprazole - Eustachian Tube Dysfunction, Laryngopharyngeal Reflux
Phase 4WithdrawnLoma Linda University2016-09-26

Narrower conditions

Otitis (6)  ·  Otitis Externa (4)  ·  Ear Diseases (3)  ·  Otitis Media (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Pain (3)  ·  Agnosia (1)  ·  Gastroesophageal Reflux (1)  ·  Laryngopharyngeal Reflux (1)  ·  Neuralgia (1)  ·  Otitis Media with Effusion (1)  ·  Temporomandibular Joint Disorders (1)

Broader conditions

Neurologic Manifestations (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Signs and Symptoms (11)  ·  Ear Diseases (8)  ·  Otorhinolaryngologic Diseases (8)  ·  Pain (8)  ·  Nervous System Diseases (2)  ·  Craniomandibular Disorders (1)  ·  Deglutition Disorders (1)  ·  Digestive System Diseases (1)  ·  Esophageal Diseases (1)  ·  Esophageal Motility Disorders (1)  ·  Gastrointestinal Diseases (1)  ·  Jaw Diseases (1)  ·  Joint Diseases (1)

Interventions

Ciprofloxacin (3)  ·  Benzocaine (2)  ·  Laryngoscopy (1)  ·  Omeprazole (1)  ·  Pantoprazole (1)  ·  Pregabalin (1)  ·  Ranitidine (1)

Sponsors

Otic Pharma (3)  ·  Arbor Pharmaceuticals, Inc. (2)  ·  Alcon Research (1)  ·  Glimpse Diagnostics, Inc. (1)  ·  Karaman Training and Research Hospital (1)  ·  Loma Linda University (1)  ·  University Hospital, Lille (1)  ·  Uşak University (1)

Countries

Israel (3)  ·  United States (3)  ·  Turkey (Türkiye) (2)  ·  France (1)

Top investigators

Yehudah Roth, MD (3)  ·  Laurence J Downey, MD (2)  ·  Gilles Lebuffe, MD, PhD (1)  ·  Helen X Xu, MD (1)

NIH funding

2014 (1), R44EB036883 (1)